Monster Beverage
MNST
$92.95
-0.30%
Monster Beverage Corporation is a leading player in the global energy drink market, operating within the non-alcoholic ready-to-drink beverage industry. The company is a dominant force known for its flagship Monster Energy brand and a portfolio that includes Reign, NOS, and Bang, and it has expanded into alcohol through the acquisition of a craft brewer. The current investor narrative revolves around its sustained growth trajectory within a competitive category and the strategic benefits of its long-term partnership with Coca-Cola, which owns a 20% stake, though attention is also focused on navigating inflationary pressures and the integration of its newer alcohol segment.…
MNST
Monster Beverage
$92.95
MNST 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Monster Beverage's 12-month outlook, with a consensus price target around $120.84 and implied upside of +30.0% versus the current price.
Average Target
$120.84
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$74 - $121
Analyst target range
Monster Beverage is covered by 13 analysts, and the institutional sentiment is overwhelmingly bullish, as evidenced by recent ratings from major firms like Deutsche Bank (Buy), Wells Fargo (Overweight), and Morgan Stanley (Overweight). The consensus recommendation is a Buy, with a notable absence of Sell ratings in recent actions. The average target price is implied by the estimated EPS and forward P/E, but specific price targets are not provided in the data; however, the high level of institutional endorsement signals strong professional conviction in the stock's outlook. The range of analyst estimates provides insight into potential outcomes; the estimated EPS for the forward period ranges from a low of $3.31 to a high of $3.71, while revenue estimates span from $12.67 billion to $13.81 billion. This relatively tight range, especially on EPS, indicates a strong consensus on the company's earnings power. The pattern of recent analyst actions shows consistent reaffirmations of Overweight/Buy/Outperform ratings following the Q4 2025 earnings report in late February, underscoring sustained confidence and reducing the likelihood of near-term negative estimate revisions.
MNST Technical Analysis
The stock is in a strong, sustained uptrend, evidenced by a 1-year price change of +45.75% and a current price of $92.83, which sits at approximately 99.7% of its 52-week high of $93.08. This positioning near the absolute top of its range suggests powerful momentum but also indicates the stock is potentially overextended and vulnerable to a pullback. The stock has demonstrated significant volatility within this uptrend, as shown by a 1-month gain of 8.03% and a 3-month gain of 20.39%, both substantially outperforming the S&P 500's returns of -0.08% and 12.0% over the same periods, respectively. This recent acceleration in momentum, particularly the sharp rally from a low near $71 in late March to current levels, confirms the primary bullish trend but also signals elevated near-term risk given the rapid ascent. Recent momentum is exceptionally strong, with the stock up 8.03% over the past month and 20.39% over the past three months, significantly outpacing the broader market. This short-term performance diverges positively from the longer-term trend, indicating accelerating bullish sentiment, likely fueled by strong quarterly results reported in late February. The stock's beta of 0.542 suggests it is approximately 46% less volatile than the S&P 500, which is unusual for such a high-growth name and implies its recent explosive moves are driven by strong company-specific fundamentals rather than broader market gyrations. Key technical support is at the 52-week low of $58.09, though a more relevant near-term support level is the March low around $71.32. Immediate resistance is the 52-week high of $93.08; a decisive breakout above this level could trigger further momentum buying. The stock's low beta of 0.542 indicates it has historically been a low-volatility stock relative to the market, but the recent 20.39% surge in three months and the 17.7% maximum drawdown highlight that it is not immune to significant corrections, suggesting risk management is crucial at these elevated levels.
Beta
0.54
0.54x market volatility
Max Drawdown
-17.7%
Largest decline past year
52-Week Range
$58-$94
Price range past year
Annual Return
+45.5%
Cumulative gain past year
| Period | MNST Return | S&P 500 |
|---|---|---|
| 1m | +6.7% | +1.5% |
| 3m | +25.5% | +13.4% |
| 6m | +23.2% | +10.9% |
| 1y | +45.5% | +24.5% |
| ytd | +22.0% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MNST Fundamental Analysis
Monster Beverage's revenue trajectory remains robust, with Q4 2025 revenue of $2.13 billion representing a 17.61% year-over-year growth. This growth is broad-based, with the core Monster Energy Drinks segment contributing $1.99 billion in the latest quarter. Sequential quarterly revenue in 2025 shows consistent strength: Q1 at $1.85B, Q2 at $2.11B, Q3 at $2.20B, and Q4 at $2.13B, indicating sustained demand. The company's net margin for Q4 2025 was a healthy 21.08%, demonstrating its ability to convert top-line growth into bottom-line profits effectively. Profitability is a key strength, with the company reporting a net income of $449.19 million in Q4 2025 and a trailing twelve-month free cash flow of $1.97 billion. Gross margin for the quarter was 55.53%, and the operating margin was 25.46%, reflecting efficient operations and pricing power. The net margin has improved significantly from 14.94% in Q4 2024 to 21.08% in Q4 2025, indicating successful margin expansion and recovery from prior cost pressures, which is a critical positive for the investment thesis. The balance sheet is exceptionally strong, featuring a debt-to-equity ratio of 0.0, indicating the company is entirely equity-financed with no debt. This is complemented by a robust current ratio of 3.70 and a trailing twelve-month free cash flow of $1.97 billion, providing immense financial flexibility for share buybacks, acquisitions, or organic investment. The return on equity (ROE) of 23.08% is impressive and underscores highly efficient use of shareholder capital, while the lack of debt eliminates interest expense risk and supports the premium valuation.
Quarterly Revenue
$2.1B
2025-12
Revenue YoY Growth
+0.17%
YoY Comparison
Gross Margin
+0.55%
Latest Quarter
Free Cash Flow
$2.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MNST Overvalued?
Given the company's consistent profitability with a positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. Monster trades at a trailing P/E of 39.27x and a forward P/E of 35.87x, based on estimated EPS of $3.545. The forward P/E being lower than the trailing multiple suggests analysts expect earnings growth to continue, with the market pricing in a forward earnings growth rate implied by a PEG ratio of 1.31. Compared to sector averages, Monster's valuation commands a significant premium. Its trailing P/E of 39.27x and Price-to-Sales (P/S) ratio of 9.02x are well above typical consumer defensive staples, reflecting its superior growth profile, high margins, and asset-light business model. The premium is justified by its industry-leading position, double-digit revenue growth, and exceptional profitability metrics like a 23% net margin and 23% ROE, which are rare for the beverage sector. Historically, the stock's current trailing P/E of 39.27x is near the higher end of its recent range, as seen in the historical data where P/E ratios have fluctuated between approximately 30x and 48x over the past few years. Trading near historical highs suggests the market has largely priced in its strong execution and growth prospects, leaving less room for multiple expansion and increasing sensitivity to any earnings disappointment or growth deceleration.
PE
39.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 30x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.9x
Enterprise Value Multiple

